Header Logo
Newsletter Podcast
Log In
← Back to all posts

Better Outcomes, Better Marketing, Bigger Impact

Jul 15, 2025
Connect

Highlights

  • Today’s Research Article: PRP Outperforms Steroids in Knee OA Relief and the Results Last.
  • Questions from the Field: It’s Not the Centrifuge, It’s What You Do With It.
  • Let’s Get Down to Business: Stop blending in. Learn how patient stories and consistency can turn followers into patients.
  • Come Join Us: Join us in Vegas this July and August for two powerful regenerative medicine experiences you won’t want to miss.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Clinical and Biochemical Correlation of Intraarticular Platelet-Rich Plasma and Corticosteroid Using Serum Matrix Metalloproteinase 3 (MMP-3) Levels in Osteoarthritis of Knee

Vaneet Arora, Manmohan Sharma, Sandeep Bishnoi, Vakul Mahipal, Angad S. Sandhu, Rajat Khanna, Tarun Aggarwal, Krishnadev S. Yadav, Gautam Jain, Shubham M. Sharma

Read the full article here.

Summary:

This study compared the clinical and biochemical outcomes of intra-articular Platelet-Rich Plasma (PRP) versus corticosteroid (CS) injections in patients with knee osteoarthritis (OA). A total of 87 patients with Kellgren-Lawrence grade II and III knee OA were randomly assigned to receive a single injection of either PRP or methylprednisolone. Outcomes were assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Visual Analogue Scale (VAS), and serum levels of Matrix Metalloproteinase-3 (MMP-3). Patients were followed up over nine months.

The findings revealed that PRP provided significantly greater and longer-lasting improvements in pain, stiffness, and joint function compared to CS, as evidenced by lower WOMAC and VAS scores at the 6- and 9-month marks. However, neither treatment led to a significant change in serum MMP-3 levels, suggesting that while both offer symptomatic relief, neither appears to alter cartilage degeneration biochemically. PRP was also found to be safe and minimally invasive, reinforcing its clinical utility in OA knee management.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP That Lasts, Better Mentorship, and What’s Next in Vegas
Highlights Today’s Research Article: PRP proves its power—lasting relief for knees, even 7 years later. Questions from the Field: When PRP isn't enough, protein concentrate might be the missing link. Let’s Get Down to Business: The right mentor can transform your clinic—and your confidence. Come Join Us: Level up your skills and strategy—join us live in Las Vegas this July and August. If thi...
MRI-Proven PRP Wins, Patient Talk Tracks and Big Wins for Your Bottom Line
Highlights Today’s Research Article: PRP Outperforms Steroids in Joint Healing — MRI-Proven. Questions from the Field: PRP = Fewer Replacements, Longer Relief — Even Years Later. Let’s Get Down to Business: Boost Practice Revenue with Cash-Based Services Patients Want. Come Join Us: Learn, Network, and Level Up — See You in Vegas!   If this newsletter was forwarded to you and you'd like to r...
Hip OA Breakthroughs, What Patients Want to Hear & Pricing Power Moves
Highlights Today’s Research Article: PRP beats HA for hip OA relief — fewer symptoms, longer results, no need to combine. Questions from the Field: “Give options, not pressure — let patients choose their outcome.” Let’s Get Down to Business: Stop undercharging: price your care like the expert you are. Come Join Us: Learn, connect, grow: BOB Live & OrthoSono are around the corner! If ...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.